Skip to main content

Future Therapies and Clinical Trials

  • Chapter
Book cover Clinical Trials in Osteoporosis

Part of the book series: Clinical Trials ((CLINICAL))

  • 735 Accesses

Abstract

The diagnosis and treatment of osteoporosis is still a relatively young science. Although Albright first described osteoporosis in 1947,1 it is only since the late 1980s and early 1990s that we have had the instruments available for the diagnosis and then treatment of this disease. As for any medical area in its infancy, we can, therefore, expect a significant number of changes in the coming years, as a result of more comprehensive understanding of bone physiology and elucidation of the genetic factors leading to increased risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albright, F. (1947). Ann Int Med 27: Osteoporosis. Nutr Rev 1989;47:85–6.

    Article  Google Scholar 

  2. Lacey, J.V., Jr, Mink, P.J., Lubin, J.H. et al. (2002). Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334–41.

    Article  PubMed  CAS  Google Scholar 

  3. Mclung, M.R., Lewiecki, M., Cohen, S.B. et al. (2006). Denosumab in postmenoausal women with low bone mineral density. New Engl J Med 354:821–31.

    Article  Google Scholar 

  4. Reid, I.R., Brown, J.P., Burckhardt, P. et al. (2002). Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density. New Engl J Med 346:653–61.

    Article  PubMed  CAS  Google Scholar 

  5. Rittmaster, R.S., Bolognese, M. and Ettinger, M.P. (2000). Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab 85:2129–34.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Miller, C.G. (2007). Future Therapies and Clinical Trials. In: Pearson, D., Miller, C.G. (eds) Clinical Trials in Osteoporosis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-587-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-587-5_14

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-389-5

  • Online ISBN: 978-1-84628-587-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics